Serum pepsinogen and Helicobacter pylori infection-a Japanese population study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 9, 2012, Pages 2117-2124

  Toyoda, K ^a   Furusyo, N ^a,b   Ihara, T ^a   Ikezaki, H ^a   Hayashi, J ^a,b   Urita, Y ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHIC GASTRITIS; DISEASE COURSE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER INFECTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; ENDOSCOPY, DIGESTIVE SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; PEPSINOGEN A; SERUM;

EID: 84866429830     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1543-0     Document Type: Article

References (38)

1. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G (1996) Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 91:959-962
2. Furusyo N, Walaa AH, Eiraku K, Toyoda K, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Kainuma M, Murata M, Hayashi J (2011) Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients. Gut Liver 5:447-453
3. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639-642
4. Sipponen P, Järvi O, Kekki M, SiuralaM(1987) Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period. Scand J Gastroenterol 22:865-871
5. Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP (1992) Changing pattern of gastric cancer in Oxfordshire. Gut 33:1312-1317
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789
7. Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K, Kawata H, Tokumaru K, Kojima T, Seki M, Ido K, Fujioka T (1998) Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 93:569-573
8. Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J (2007) Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan. Helicobacter 12:170-176
9. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161-1181
10. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY (2007) Gastritis staging in clinical practice: the OLGA staging system. Gut 56:631-636
11. Samloff IM (1971) Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 61:185-188
12. Samloff IM, Liebman WM (1973) Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 65:36-42
13. Huang SC, Miki K, Sano J, Ichinose M, Kawamura N, Oka H, Hirano K, Furihata C, Masugi Y, Takahashi K (1988) Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies. Jpn J Cancer Res 79:1139-1146
14. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K (1987) Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 22:133-141
15. Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y, Suzuki T, Kurokawa K (1993) Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 84:1086-1090
16. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI (1982) Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 83:204-209
17. Weck MN, Brenner H (2006) Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 15:1083-1094
18. Weck MN, Stegmaier C, Rothenbacher D, Brenner H (2007) Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 26:879-887
19. Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 30:751-758
20. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2011) Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 54:3028-3036
21. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39:888-891
22. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85-92
23. Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T (1996) Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl 214:17-20
24. Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T, Graham DY (2003) Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol 41:1480-1485
25. Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H, Oka H, Matsushima T, Takahashi K (1982) Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 126:183-191
26. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98:735-739
27. Kim HY, Kim N, Kang JM, Park YS, Lee DH, Kim YR, Kim JS, Jung HC, Song IS (2009) Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea. Eur J Gastroenterol Hepatol 21:606-612
28. Jansen JB, Klinkenberg-Knol EC, Meuwissen SG, De Bruijne JW, Festen HP, Snel P, Lückers AE, Biemond I, Lamers CB (1990) Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 99:621-628
29. Plebani M (1993) Pepsinogens in health and disease. Crit Rev Clin Lab Sci 30:273-328
30. Rieu PN, Jansen JB, Joosten HJ, Biemond I, Yap SH, Lamers CB (1989) Prospective comparison of gastric secretory function after gastrectomy with either Billroth II or Roux-en-Y anastomosis. Surgery 105:331-336
31. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM (2005) Atrophic gastritis in young children and adolescents. J Clin Pathol 58:1189-1193
32. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151:121-128
33. Wong BC, Lam SK,Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291:187-194
34. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M (1985) Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35:173-177
35. Webb PM, Hengels KJ, Møller H, Newell DG, Palli D, Elder JB, Coleman MP, De Backer G, Forman D (1994) The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology 107:1335-1344
36. Furukawa H, Iwanaga T, Koyama H, Taniguchi H (1982) Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 42:5181-5182
37. Fukao A, Hisamichi S, Ohsato N, Fujino N, Endo N, Iha M (1993) Correlation between the prevalence of gastritis and gastric cancer in Japan. Cancer Causes Control 4:17-20
38. Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Tamai H, Arii K, Nakata H, Yoshimura N, Takeshita T, Miki K, Mohara O, Ichinose M (2005) Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 96:713-720